Article date: 1987/12/1
PubMed ID: 2893987
Journal name: Neuropharmacology (ISSN: 0028-3908)
Possible functional coupling between gamma-aminobutyric acid (GABA) and benzodiazepine receptors was examined using a purified GABA/benzodiazepine receptor complex. The purified receptor complex was obtained by 1012-S-acetamide adipic hydrazide Sepharose 4B affinity column chromatography, following the solubilization of synaptic membrane from the bovine cerebral cortex with Nonidet P-40. The binding of [3H]GABA to the purified GABA receptor was displaced significantly by muscimol and bicuculline, GABAA receptor agonists and antagonists, respectively, but not by baclofen, a GABAB receptor agonist. On the other hand, the binding of [3H]flunitrazepam to the purified benzodiazepine receptor was found to be displaced by microM ranges of CL 218,872, which is known to be sensitive to the benzodiazepine type II receptor. Furthermore, it was found that the binding of [3H]muscimol to these purified GABAA receptors was enhanced by benzodiazepines, while the binding of [3H]flunitrazepam to these benzodiazepine type II receptors was increased by GABA receptor agonists. These enhancements by GABA agonists and benzodiazepine agonists were found to be blocked by bicuculline and a benzodiazepine receptor antagonist, Ro15-1788, respectively. These results strongly suggest that the purified receptor may consist of GABAA and benzodiazepine type II receptors and possess a functional coupling of these sites, as shown in cerebral synaptic membranes.
Author List: Taguchi J, Kuriyama K
Publication Types: Journal Article; Research Support, Non-U.S. Gov't
Substances mentioned in the article: Antipsychotic Agents; Pyridazines; Receptors, GABA-A; Muscimol; Flumazenil; Flunitrazepam; CL 218872; Bicuculline;
Mesh terms: Animals; Antipsychotic Agents/pharmacology; Bicuculline/pharmacology; Cattle; Cerebral Cortex/metabolism; Flumazenil/pharmacology; Flunitrazepam/metabolism; In Vitro Techniques; Kinetics; Muscimol/metabolism; Pyridazines/pharmacology; Receptors, GABA-A/isolation & purification;